Mutant KRAS driven cancers have been implicated in cell signaling and tumour metabolic remodelling in an environment dependent manner, mediated through cross-talk with surrounding stromal compartment [56] and differing according to tissue of origin [57]. This evidence concerns the gene KRAS and neoplasm.